LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and restore mobility for patients. This novel technology provides a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation. For additional information, please visit www.limflow.com.
Looking for a particular LimFlow SA employee's phone or email?
The LimFlow SA annual revenue was $5.3 million in 2026.
20 people are employed at LimFlow SA.
LimFlow SA is based in Paris, Ile-de-France.
The NAICS codes for LimFlow SA are [339, 33].
The SIC codes for LimFlow SA are [38, 384].